BLUEPRINT MEDICINES CORP

Profile

Company Names

BLUEPRINT MEDICINES CORP

Addresses

215 FIRST STREET, SUITE 340/350, CAMBRIDGE, MA 02142

215 FIRST STREET, CAMBRIDGE, MA 02142

Phone Numbers

617-374-7580

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$73,199,996.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2014-11-10 
$50,000,000.00 
$50,000,000.00 
$0.00 
Equity 
1
2014-01-06 
$23,199,996.00 
$25,099,995.00 
$1,899,999.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEFFREY 
W. 
ALBERS 
EXECUTIVE OFFICER, DIRECTOR
BLUEPRINT MEDICINES CORP   |  SPYRE THERAPEUTICS, INC.
CHRISTINE 
 
BELLON 
EXECUTIVE OFFICER
BLUEPRINT MEDICINES CORP
ALEXIS 
 
BORISY 
DIRECTOR, EXECUTIVE OFFICER
FOUNDATION MEDICINE, INC.   |  FORMA THERAPEUTICS HOLDINGS LLC   |  BLUEPRINT MEDICINES CORP   |  EDITAS MEDICINE, INC.   |  REVOLUTION MEDICINES, INC.   |  THIRD ROCK VENTURES IV, L.P.   |  MAGENTA THERAPEUTICS, INC.   |  CELSIUS THERAPEUTICS, INC.   |  TANGO THERAPEUTICS, INC.   |  RELAY THERAPEUTICS, INC.   |  CURIE BIO SERIES A FUND I, L.P.   |  CURIE BIO SEED FUND II, L.P.   |  CURIE BIO SEED FUND II-A, L.P.
STEPHEN 
 
KNIGHT 
DIRECTOR
IRONWOOD PHARMACEUTICALS INC   |  US GENOMICS INC   |  IORA HEALTH, INC.   |  BLUEPRINT MEDICINES CORP   |  PROTEOSTASIS THERAPEUTICS, INC.   |  SEMMA THERAPEUTICS, INC.   |  BEAM THERAPEUTICS INC.   |  SANA BIOTECHNOLOGY, INC.   |  ENSOMA, INC.   |  QUANTUM CIRCUITS, INC.   |  QUARRY GLUE HOLDING CO LLC
KYLE 
 
KUVALANKA 
EXECUTIVE OFFICER
BLUEPRINT MEDICINES CORP   |  GOLDFINCH BIO, INC.   |  IMV INC.
CHRISTOPH 
S. 
LENGAUER 
EXECUTIVE OFFICER
BLUEPRINT MEDICINES CORP
NICHOLAS 
 
LYDON 
DIRECTOR
BLUEPRINT MEDICINES CORP   |  ANAPTYSBIO INC
NICK 
 
LYDON 
DIRECTOR
ANAPTYSBIO INC   |  BLUEPRINT MEDICINES CORP
DANIEL 
 
LYNCH 
DIRECTOR
AVILA THERAPEUTICS INC   |  STROMEDIX INC   |  BLUEPRINT MEDICINES CORP   |  RANA THERAPEUTICS, LLC   |  PROCLARA BIOSCIENCES, INC.   |  RANA THERAPEUTICS, INC.   |  SPRINGWORKS THERAPEUTICS, LLC   |  XILIO THERAPEUTICS, INC.   |  2SEVENTY BIO, INC.   |  CARDURION PHARMACEUTICALS, INC.   |  GU CAPITAL LP
DAVID 
 
SCHENKEIN 
DIRECTOR
AGIOS PHARMACEUTICALS INC   |  FOUNDATION MEDICINE, INC.   |  BLUEPRINT MEDICINES CORP   |  TREELINE BIOSCIENCES, INC.
THILO 
 
SCHROEDER 
DIRECTOR
BLUEPRINT MEDICINES CORP   |  IMAGINAB, INC.   |  IDEAYA BIOSCIENCES, INC.   |  REVOLUTION MEDICINES, INC.   |  SILVERBACK THERAPEUTICS, INC.   |  CIRCLE PHARMA, INC.   |  ALTEROME THERAPEUTICS, INC.   |  NEXTECH VII ONCOLOGY SCSP   |  NEXTECH CROSSOVER I SCSP   |  NEXTECH VII CARRY SCSP   |  NEXTECH CROSSOVER I CARRY SCSP   |  NEXTECH VIII SCSP   |  STIPPLE BIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-11-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-10 
2014-01-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#